Belite Bio (BLTE) EPS (Basic) (2022 - 2026)
Belite Bio (BLTE) recorded quarterly EPS (Basic) of -$0.68 in Q1 2026, up 2.86% quarter-over-quarter from -$0.7 in Q4 2025, and down 51.11% on a YoY basis from -$1.39 in Q1 2025.
Belite Bio (BLTE) EPS (Basic) (2022 - 2026) Analysis & Trends
Belite Bio's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.68 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 51.11% year-over-year to -$0.68; the TTM figure through Mar 2026 stood at -$1.53 (down 12.5% YoY), while the FY2025 annual figure was -$2.31, down 95.76% from the prior year.
- EPS (Basic) was -$0.68 for Q1 2026 at Belite Bio, up from -$0.7 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.5 in Q2 2025 to a low of -$0.7 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.17 across 5 years, with a median of -$0.28 in 2022.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) jumped 500.0% in 2023, then tumbled 266.67% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.27 in 2022, then climbed by 7.41% to -$0.25 in 2023, then dropped by 28.0% to -$0.32 in 2024, then sank by 118.75% to -$0.7 in 2025, then rose by 2.86% to -$0.68 in 2026.
- The last three EPS (Basic) figures came in at -$0.68 (Q1 2026), -$0.7 (Q4 2025), and -$0.65 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.68 |
| Dec 31, 2025 | -0.70 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | 0.50 |
| Mar 31, 2025 | -0.45 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -0.31 |
| Mar 31, 2024 | 0.27 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | 0.40 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | -0.33 |
| Dec 31, 2022 | -0.27 |
| Sep 30, 2022 | -0.10 |
| Jun 30, 2022 | 0.12 |